SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016497
Filing Date
2022-08-10
Accepted
2022-08-10 16:31:37
Documents
56
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hlvx-20220630.htm   iXBRL 10-Q 2005985
2 EX-31.1 hlvx-ex31_1.htm EX-31.1 21623
3 EX-31.2 hlvx-ex31_2.htm EX-31.2 21587
4 EX-32.1 hlvx-ex32_1.htm EX-32.1 12517
5 EX-32.2 hlvx-ex32_2.htm EX-32.2 12493
  Complete submission text file 0000950170-22-016497.txt   7638558

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hlvx-20220630_cal.xml EX-101.CAL 46122
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hlvx-20220630_lab.xml EX-101.LAB 436659
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hlvx-20220630_pre.xml EX-101.PRE 316956
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hlvx-20220630.xsd EX-101.SCH 50029
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hlvx-20220630_def.xml EX-101.DEF 177566
50 EXTRACTED XBRL INSTANCE DOCUMENT hlvx-20220630_htm.xml XML 1378854
Mailing Address 75 STATE ST. SUITE 100 BOSTON MA 02109
Business Address 75 STATE ST. SUITE 100 BOSTON MA 02109 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41365 | Film No.: 221152260
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences